Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient.
Arpas T, Jelinkova H, Hrabovsky S, Orsulova M, Vrzalova Z, Navrkalova V, Brhelova E, Bryjova L, Bulikova A, Ondrouskova E, Sejnohova M, Folber F, Sedová P, Mayer J, Pospisilova S, Jarosova M, Doubek M. Arpas T, et al. Among authors: hrabovsky s. Clin Case Rep. 2022 Mar 3;10(3):e05545. doi: 10.1002/ccr3.5545. eCollection 2022 Mar. Clin Case Rep. 2022. PMID: 35280086 Free PMC article.
Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia.
Hrabovsky S, Folber F, Horacek JM, Stehlikova O, Jelinkova H, Salek C, Doubek M; Czech Leukemia Study Group for Life. Hrabovsky S, et al. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):743-748. doi: 10.1016/j.clml.2018.06.030. Epub 2018 Jul 4. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30057330
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Šálek C, Folber F, Froňková E, Pecherková P, Jelínková H, Hrabovský Š, Horáček JM, Cetkovský P, Mayer J, Trka J, Doubek M; Czech Leukemia Study Group - for Life (CELL). Šálek C, et al. Among authors: hrabovsky s. Br J Haematol. 2022 Feb;196(3):706-710. doi: 10.1111/bjh.17966. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816424
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Chevallier P, Leguay T, Delord M, Salek C, Kim R, Huguet F, Hicheri Y, Wartiovaara-Kautto U, Raffoux E, Cluzeau T, Balsat M, Roth-Guepin G, Tavernier E, Lepretre S, Bilger K, Bergugnat H, Berceanu A, Alexis M, Doubek M, Brissot E, Hunault-Berger M, Lebon D, Turlure P, Chantepie S, Belhabri A, Wickenhauser S, Bastie JN, Cacheux V, Himberlin C, Banos A, Gardin C, Bonnet S, Plantier I, Pica GM, Escoffre-Barbe M, Boissel N, Dombret H, Clappier E, Rousselot P; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) and the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL). Chevallier P, et al. J Clin Oncol. 2024 Oct 17:JCO2400490. doi: 10.1200/JCO.24.00490. Online ahead of print. J Clin Oncol. 2024. PMID: 39418626
COVID-19's natural course among ambulatory monitored outpatients.
Weinbergerova B, Mayer J, Hrabovsky S, Novakova Z, Pospisil Z, Martykanova L, Hortova K, Mandelova L, Hejduk K, Chloupková R, Pospisil M, Doubkova M, Marek V, Novotna R, Dolecek M, Kubesova HM, Brat K, Parizkova R, Husa P, Mechl M, Kral Z, Lengerova M. Weinbergerova B, et al. Among authors: hrabovsky s. Sci Rep. 2021 May 12;11(1):10124. doi: 10.1038/s41598-021-89545-1. Sci Rep. 2021. PMID: 33980931 Free PMC article.
54 results